XWPharma 凯瑞康宁 raised $40M Series C venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$57.5M
Top Valuation
-
XWPharma 凯瑞康宁 raised $40M in a Series C round.
The round was announced on 09/20/20.